SCHEMBL10385683

SCHEMBL10385683

COCc1ccccc1C(O)c1cccs1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TOP2A P11388 2/20 0.42
TOP2B Q02880 2/20 0.42
EGFR P00533 1/20 0.42
CNR2 P34972 1/20 0.39
TSHR P16473 1/20 0.38
MAPT P10636 2/20 0.38
HSD17B10 Q99714 1/20 0.38
NPC1 O15118 2/20 0.37
RAB9A P51151 2/20 0.37
SLC5A2 P31639 1/20 0.36
HTR1A P08908 1/20 0.35
DPP4 P27487 1/20 0.35
CES2 O00748 1/20 0.34
CES1 P23141 1/20 0.34
KEAP1 Q14145 1/20 0.34
KMT2A Q03164 1/20 0.34
IDO1 P14902 1/20 0.34
TDO2 P48775 1/20 0.34
TP53 P04637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2889829 0.73 PDK2 (0.36) TSHRMAPTKEAP1KMT2A
SCHEMBL23489760 0.73 PDK2 (0.36) TSHRMAPTKEAP1KMT2A
SCHEMBL18892819 0.72 PDK2 (0.36) TSHRMAPTNPC1RAB9AKMT2A
SCHEMBL6154951 0.72 TOP2A (0.54) TOP2ATOP2BEGFRCNR2TSHR
SCHEMBL11734140 0.70 TOP2A (0.48) TOP2ATOP2BEGFRCNR2TSHR
SCHEMBL1384962 0.70 TSHR (0.57) TOP2ATOP2BEGFRCNR2TSHR
SCHEMBL6375190 0.70 TSHR (0.48) TOP2ATOP2BEGFRCNR2TSHR
SCHEMBL9968895 0.69 GABRA1 (0.41) TSHRKMT2AIDO1
SCHEMBL1200951 0.68 TSHR (0.41) TSHRMAPTHSD17B10KMT2A
SCHEMBL4239389 0.68 FABP4 (0.48) TSHRKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4914127-A HYDROXYMETHYLGLUTARIC ACID-COENZYME A REDUCTASE INHIBITORS HOECHST AKTIENGESELLSCHAFT (DE) 1990-04-03 US disclosed
EP-0217092-A2 3-Dimethyl-mevalonic-acid derivatives, process for their preparation, pharmaceutical compositions based on these compounds, their use and intermediates HOECHST AKTIENGESELLSCHAFT (DE) 1987-04-08 EP disclosed